Literature DB >> 20610493

Pregnancy-induced fluctuations in functional T-cell subsets in multiple sclerosis patients.

Rinze F Neuteboom1, Evert Verbraak, Annet F Wierenga-Wolf, Marjan van Meurs, Eric A P Steegers, Christianne J M de Groot, Jon D Laman, Rogier Q Hintzen.   

Abstract

BACKGROUND: During pregnancy, especially during the third trimester, multiple sclerosis (MS) disease activity is reduced. It is not known which factors mediate this disease amelioration.
OBJECTIVE: To study whether the frequency of two important T-cell subsets, T-helper 17 (Th17) and regulatory T-cells (Treg), is altered in relation to pregnancy-induced MS disease amelioration.
METHODS: Each individual was tested longitudinally, after sampling of blood at timepoints before pregnancy, during the first and third trimester, and in the early post-partum period. Frequencies of Th17 cells were assessed after short (4 hours) re-stimulation of peripheral blood lymphocytes with PMA and ionomycin, followed by flow cytometry using CD4, CD45RO and IL-17A antibodies. To assess peripheral blood Treg frequencies, we used six-colour flow cytometry with antibodies against CD3, CD4, CD25, CD127, FoxP3 and HLA-DR, to specifically identify Treg.
RESULTS: Both MS patients (n = 9) and controls (n = 8) displayed unaltered Th17 frequencies during pregnancy. In contrast, circulating Treg frequency significantly decreased in MS patients (n = 15) during the first and third (p < 0.001) trimesters compared with the period before pregnancy. In the post-partum period, the frequency of circulating Treg again resurged back to near pre-pregnancy levels. In controls (n = 15) comparable frequency kinetics were observed in that post-partum a significant increase in circulating Treg frequency was detected compared with the first (p < 0.001) and third (p = 0.012) trimester.
CONCLUSIONS: Third trimester amelioration is not related to the fluctuation of circulating Th17 cells. Furthermore, a paradoxical decrease of immunosuppressive circulating Tregs can be observed during this phase, both in MS patients and controls.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610493     DOI: 10.1177/1352458510373939

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  11 in total

1.  Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs.

Authors:  A Steinborn; E Schmitt; A Kisielewicz; S Rechenberg; N Seissler; K Mahnke; M Schaier; M Zeier; C Sohn
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 2.  The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders.

Authors:  Lauren M Osborne; Amitoj Brar; Sabra L Klein
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

3.  Women's Pregnancy Life History and Alzheimer's Risk: Can Immunoregulation Explain the Link?

Authors:  Molly Fox; Carlo Berzuini; Leslie A Knapp; Laura M Glynn
Journal:  Am J Alzheimers Dis Other Demen       Date:  2018-07-30       Impact factor: 2.035

Review 4.  Sex-related factors in multiple sclerosis susceptibility and progression.

Authors:  Rhonda R Voskuhl; Stefan M Gold
Journal:  Nat Rev Neurol       Date:  2012-03-27       Impact factor: 42.937

Review 5.  The T helper type 17/regulatory T cell paradigm in pregnancy.

Authors:  Ana Sofia Figueiredo; Anne Schumacher
Journal:  Immunology       Date:  2016-05       Impact factor: 7.397

6.  Immunometabolic adaptation and immune plasticity in pregnancy and the bi-directional effects of obesity.

Authors:  April Rees; Oliver Richards; Megan Chambers; Benjamin J Jenkins; James G Cronin; Catherine A Thornton
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

Review 7.  Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Semin Immunopathol       Date:  2016-08-08       Impact factor: 9.623

8.  Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis.

Authors:  Andrea Iannello; Simona Rolla; Alessandro Maglione; Giulio Ferrero; Valentina Bardina; Ilenia Inaudi; Stefania De Mercanti; Francesco Novelli; Lucrezia D'Antuono; Simona Cardaropoli; Tullia Todros; Maria Vittoria Turrini; Cinzia Cordioli; Giorgia Puorro; Angela Marsili; Roberta Lanzillo; Vincenzo Brescia Morra; Francesca Cordero; Michele De Bortoli; Luca Durelli; Andrea Visconti; Santina Cutrupi; Marinella Clerico
Journal:  Front Immunol       Date:  2019-01-08       Impact factor: 7.561

9.  Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.

Authors:  Michela Spadaro; Serena Martire; Luca Marozio; Daniela Mastromauro; Elena Montanari; Simona Perga; Francesca Montarolo; Federica Brescia; Alessia Balbo; Giovanni Botta; Chiara Benedetto; Antonio Bertolotto
Journal:  Front Immunol       Date:  2019-08-16       Impact factor: 7.561

10.  Pregnancy-induced effects on memory B-cell development in multiple sclerosis.

Authors:  Rinze Neuteboom; Joost Smolders; Malou Janssen; Liza Rijvers; Steven C Koetzier; Annet F Wierenga-Wolf; Marie-José Melief; Jamie van Langelaar; Tessel F Runia; Christianne J M de Groot; Marvin M van Luijn
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.